Drug Repurposing for Triple-Negative Breast Cancer
Metadatos
Afficher la notice complèteAuteur
Ávalos Moreno, Marta; López Tejada, Araceli; Blaya Cánovas, José L.; Cara Lupiáñez, Francisca E.; González González, Adrián; Lorente Acosta, José Antonio; Sánchez Rovira, Pedro; Granados Principal, SergioEditorial
Mdpi
Materia
Triple-negative breast cancer Personalized medicine Computational methods Drug repurposing Clinical trials Cancer stem cells
Date
2020-10-29Referencia bibliográfica
Ávalos-Moreno, M., López-Tejada, A., Blaya-Cánovas, J. L., Cara-Lupiañez, F. E., González-González, A., Lorente, J. A., ... & Granados-Principal, S. (2020). Drug repurposing for triple-negative breast cancer. Journal of Personalized Medicine, 10(4), 200. [doi:10.3390/jpm10040200]